Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Kelly Van Lancker

Publications & Research Data

Awards & Distinctions

18 Results

2025

Chasing shadows : how implausible assumptions skew our understanding of causal estimands

Stijn VansteelandtKelly Van Lancker

A1 Journal Article in STATISTICS IN BIOPHARMACEUTICAL RESEARCH

Rejoinder to the discussion on 'Chasing shadows : how implausible assumptions skew our understanding of causal estimands'

Stijn VansteelandtKelly Van Lancker

Editorial material

2024

Assumption-lean cox regression

Stijn VansteelandtOliver DukesKelly Van LanckerTorben Martinussen

A1 Journal Article in JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION

Coping with information loss and the use of auxiliary sources of data : a report from the NISS Ingram Olkin Forum Series on unplanned clinical trial disruptions

Silvia CalderazzoSergey TarimaCarissa ReidNancy FlournoyTim FriedeNancy GellerJames L RosenbergerNigel StallardMoreno UrsinoMarc Vandemeulebroecke et al.

A1 Journal Article in STATISTICS IN BIOPHARMACEUTICAL RESEARCH

Covariate adjustment in randomized controlled trials : general concepts and practical considerations

Kelly Van LanckerFrank BretzOliver Dukes

A1 Journal Article in CLINICAL TRIALS

Response to Harrell’s commentary

Kelly Van LanckerFrank BretzOliver Dukes

A1 Journal Article in CLINICAL TRIALS

2023

Ensuring valid inference for cox hazard ratios after variable selection

Kelly Van LanckerOliver DukesStijn Vansteelandt

A1 Journal Article in BIOMETRICS

Estimands and their estimators for clinical trials impacted by the COVID-19 pandemic : a report from the NISS Ingram Olkin Forum Series on unplanned clinical trial disruptions

Kelly Van LanckerSergey TarimaJonathan BartlettMadeline BauerBharani Bharani-DharanFrank BretzNancy FlournoyHege MichielsCamila Olarte ParraJames L. Rosenberger et al.

A1 Journal Article in STATISTICS IN BIOPHARMACEUTICAL RESEARCH

PROMISE : effect of protein supplementation on fat-free mass preservation after bariatric surgery, a randomized double-blind placebo-controlled trial

A. E. TaselaarA. J. BoesR. W. F. de BruinT. M. KuijperKelly Van LanckerE. van der HarstR. A. Klaassen

A1 Journal Article in TRIALS

Rejoinder : estimands and their estimators for clinical trials impacted by the COVID-19 pandemic : a report from the NISS Ingram Olkin Forum Series on unplanned clinical trial disruptions

Kelly Van LanckerSergey TarimaJonathan BartlettMadeline BauerBharani Bharani-DharanFrank BretzNancy FlournoyHege MichielsCamila Olarte ParraJames L Rosenberger et al.

Editorial material

Single-arm studies involving patient-reported outcome data in oncology : a literature review on current practice

Limin LiuJungyeon ChoiJammbe Z. MusoroWilli SauerbreiCecilie Delphin AmdalAhu AlanyaYolanda BarbachanoJoseph C. CappelleriRagnhild Sørum FalkMallorie H. Fiero et al.

A1 Journal Article in LANCET ONCOLOGY

2021

Efficient, doubly robust estimation of the effect of dose switching for switchers in a randomized clinical trial

Kelly Van LanckerAn VandeboschStijn Vansteelandt

A1 Journal Article in BIOMETRICAL JOURNAL

On identification of the principal stratum effect in patients who would comply if treated

Oliver DukesKelly Van LanckerBjörn BornkampDominik HeinzmannKaspar RufibachMarcel Wolbers

A1 Journal Article in STATISTICS IN BIOPHARMACEUTICAL RESEARCH

Optimizing treatment effect estimation in randomized trials by leveraging baseline covariates and early read-outs

Kelly Van LanckerStijn VansteelandtAn Vandebosch

Principled selection of baseline covariates to account for censoring in randomized trials with a survival endpoint

Kelly Van LanckerOliver DukesStijn Vansteelandt

A1 Journal Article in STATISTICS IN MEDICINE

2020

Clinical trials impacted by the COVID-19 pandemic : adaptive designs to the rescue?

Cornelia Ursula KunzSilke JörgensFrank BretzNigel StallardKelly Van LanckerDong XiSarah ZoharChristoph GerlingerTim Friede

A1 Journal Article in STATISTICS IN BIOPHARMACEUTICAL RESEARCH

Improving interim decisions in randomized trials by exploiting information on short-term endpoints and prognostic baseline covariates

Kelly Van LanckerAn VandeboschStijn Vansteelandt

A1 Journal Article in PHARMACEUTICAL STATISTICS

2019

Evaluating futility of a binary clinical endpoint using early read‐outs

Kelly Van LanckerAn VandeboschStijn VansteelandtFilip De Ridder

A1 Journal Article in STATISTICS IN MEDICINE